Prasol Chemicals IPO

₹14,872 / 22 shares

Issue Date

08 Sep - 10 Sep'26

Price Band

₹643 - ₹676

Lot Size

22 Shares

IPO Size

₹₹500 Cr Cr

Listing At

BSE and NSE

Schedule of Prasol Chemicals IPO

IPO Open Date

08/09/2026

IPO Close Date

10/09/2026

Basis of Allotment

11/09/2026

Refund Initiation

15/09/2026

Credit of Shares

15/09/2026

Listing on exchange

16/09/2026

The Prasol Chemicals IPO, a mainboard IPO, opens on Tuesday, September 8, 2026 and closes on Thursday, September 10, 2026. The allotment of shares will take place on Friday, September 11, 2026. The credit of shares to the demat account will take place on Tuesday, September 15, 2026. The initiation of refunds will take place on Tuesday, September 15, 2026. The listing of shares will take place on Wednesday, September 16, 2026.

The equity shares offered through the IPO are proposed to be listed on the BSE and the NSE.

The offer consists of both a fresh issue and an offer for sale component. The fresh issue will include 11,83,431 shares aggregating up to ₹80 crore. The offer for sale portion includes 62,13,006 shares aggregating up to ₹420 crore. The total number of shares and aggregate amount are 73,96,437 shares aggregating up to ₹500 crore.

Prasol Chemicals IPO's price band is set at ₹643 to ₹676 per share. The lot size for an application is 22. The minimum amount of investment required by a retail investor is ₹14,872 based on upper price.

Prasol Chemicals is a forward-integrated manufacturer of acetone-based and phosphorous-based specialty chemicals, with a portfolio of over 150 products. It serves more than 1,600 custome ₹across five application industries and exports to 69 countries from its two manufacturing facilities in Maharashtra.

  • Repayment and/or pre-payment, in full or in part, of certain borrowings availed by the Company.

  • General corporate purposes.

Specialty chemicals are performance-driven inputs. They are sold to downstream manufacturers rather than as bulk commodities, and their value lies in the function they deliver to an end product.

Asia-Pacific leads. The region held a 52% share of the global specialty chemicals market as of CY25, and that share is expected to rise to 54% by CY29 as manufacturing shifts eastward. The Indian specialty chemicals market expanded from ₹2,240 billion in FY19 to ₹5,563 billion in FY26, and is projected to reach ₹7,541 billion by FY29, registering a CAGR of 10-12%.

Prasol Chemicals manufactures acetone-based and phosphorous-based specialty chemicals that feed five application industries. This spread across performance chemicals, coatings, pharmaceuticals, agrochemicals, and home and personal care lets the Company draw on demand from several end markets rather than a single one.

Prasol Chemicals is a forward-integrated manufacturer of acetone-based and phosphorous-based specialty chemicals. As of July 15, 2026 it had a portfolio of over 150 specialty chemical products, more than 1,600 customers, and exports to 69 countries across six continents. The chemistries it operates are complex and differentiated, which raises the barrier for competiton seeking to replicate its range.

The company runs two manufacturing facilities. Both are located in Maharashtra, at Khopoli and Mahad, alongside a dedicated research and development centre. Aggregate installed capacity across the two sites rose to 98,644 tonnes per annum in Fiscal 2026, with the Khopoli facility operating at 80.29% utilisation and the Mahad facility at 44.09%.

The company was the largest importer of acetone in India and the only manufacturer of isophorone in the country. It was also among the top five users of yellow phosphorous in India during that period.

  • Prasol Chemicals manufactures over 150 specialty chemical products for more than 1,600 customers and exports to 69 countries across six continents as of July 15, 2026.

  • During the calendar year 2022 to 2025, the Company was the largest importer of acetone in India and the only manufacturer of isophorone in the country.

  • A base of 1,618 customers in Fiscal 2026, with no single customer contributing more than 5.00% of total income, reduces revenue-concentration risk.

  • The company operates a 37-member in-house R&D team, including 4 PhD holders and 25 chemists, and has commercialised 13 new products since April 1, 2023.

  • Aggregate installed capacity across the Khopoli and Mahad facilities rose to 98,644 tonnes per annum in Fiscal 2026, supporting continued revenue growth.

  • The company's output depends on two facilities in Maharashtra, and the Mahad facility was shut by the MPCB from October 27, 2023 to May 3, 2024, so any similar closure could halt production and cut revenue.

  • Several raw materials, byproducts, and finished products are hazardous, corrosive, and flammable, and an accident could cause loss of life or property and disrupt operations.

  • Imports made up 65.96% of raw-material procurement cost in Fiscal 2026, exposing the Company to foreign-exchange and supply-chain shocks that could raise input costs and compress margins.

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...

Notes: Financial information of the peer group companies has been sourced from the consolidated financial statements for the year ended March 31, 2026 as disclosed on the website of the Stock Exchanges.

Diluted EPS refers to the diluted EPS sourced from the consolidated financial statements of the respective peer group companies for the year ended March 31, 2026.

NAV is computed as the closing net worth divided by the closing outstanding number of equity shares as on March 31, 2026.

The P/E ratio for peers is computed based on the closing market price of equity shares on BSE on August 28, 2026, divided by the diluted EPS.

Monday, September 7, 2026

Registrar Details

KFin Technologies Limited

Tel: +91 40 6716 2222/ 1800 309 4001

E-mail: prasol.ipo@kfintech.com

Book Running Lead Manager

DAM Capital Advisors Limited

Prasol Chemicals Contact Details

Prasol House, Plot No A - 17/2/3, T.T. C, Industrial Area, Khairne, M.I.D.C., Navi Mumbai, Thane, Maharashtra – 400710, India

Email: investorservices@prasolchem.com

Phone: +91 22 6195 2500

The company earns its revenue through the manufacture and sale of acetone-based and phosphorous-based specialty chemicals, together with other customised specialty chemicals. Prasol Chemicals operates a business-to-business-to-consumer (B2B2C) model, supplying the performance chemicals; paints, inks, construction, and adhesives (PICA); pharmaceuticals; agrochemicals; and home and personal care industries.

Prasol Chemicals Limited's Total Income for FY26 was ₹1,237.85 crore, whereas in FY25 and FY24 it was ₹1,015.54 crore and ₹887.56 crore, respectively.

The Profit After Tax for FY26 was ₹83.12 crore, whereas in FY25 and FY24 it was ₹43.57 crore and ₹18.13 crore, respectively.

Their EBITDA for FY26 was ₹139.32 crore, whereas in FY25 and FY24 it was ₹87.77 crore and ₹60.53 crore, respectively.

Prasol Chemicals distributes its products to more than 1,600 customers across 69 countries spanning six continents and holds a Government of India 3 Star Export House certification. It is a certified Authorised Economic Operator with Indian Customs and a member of CHEMEXCIL, and it has obtained European REACH and Korea K-REACH registrations for some of its products. Its marquee customers include Alembic Pharmaceuticals Limited, Clean Science and Technology Limited, Coromandel International Limited, and Lubrizol India Private Limited.

As of 31 March 2026, the company's Total Income, Profit After Tax, and EBITDA were ₹1,237.85 crore, ₹83.12 crore, and ₹139.32 crore, respectively.

Note: () denotes negative

To apply for this IPO:

  • Log in to your Kotak Neo Demat account: Log in to your Demat account to access IPO investments. Next, select the current IPO section.
  • Specify IPO details: Enter the number of lots and the price you wish to apply for.
  • Enter UPI ID: After entering your UPI ID, click submit. This will place your bid with the exchange.
  • Mandate Notification: Your UPI app will receive a mandate notification to block funds.
  • Approve Request: Your funds will be blocked once you approve the mandate request on your UPI.

The Prasol Chemicals IPO opens for subscription from 08-09-2026 to 10-09-2026, with a total issue size of ₹₹500 Cr Cr. The IPO price band is ₹643 to ₹676 per share with a lot size of 22. The company aims to list the shares on BSE & NSE on 16-09-2026.

The Prasol Chemicals IPO will open for subscription on 08-09-2026 and will close on 10-09-2026 for investors.

The minimum lot size for the Prasol Chemicals IPO is 22 equity shares, requiring a minimum investment of ₹14872 for retail investors applying in the IPO.

The price band of the Prasol Chemicals IPO has been fixed at ₹643 to ₹676 per equity share.

You can apply for the Prasol Chemicals IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.

Prasol Chemicals IPO allotment will take place on 11-09-2026.

You can check the Prasol Chemicals IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.

Prasol Chemicals shares will list on the stock exchanges on 16-09-2026.

The exact dates of the IPO are yet to be announced.

Nishith Rajnikant Shah is the Chairman and Whole-time Director of Prasol Chemicals Limited.

The lot size of shares in this IPO is yet to be announced.

You can read more about Prasol Chemicals and its IPO from the company’s draft red herring prospectus here.

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.